STAAR SURGICAL CO·4

Mar 10, 7:05 PM ET

LeBuhn Richard T. 4

Research Summary

AI-generated summary

Updated

STAAR SURGICAL (STAA) Director Richard LeBuhn Receives Option Award

What Happened Richard T. LeBuhn, a director of STAAR SURGICAL CO (STAA), was granted 7,524 stock option awards on March 6, 2026. The grant is reported as a derivative award with a transaction price of $0.00 (i.e., no cash paid for the grant). These are option awards rather than immediate share issuances.

Key Details

  • Transaction date: March 6, 2026; Form 4 filed March 10, 2026 (appears timely—filed within two business days).
  • Security: 7,524 options granted (reported as derivative securities; transaction code A = Award/Grant).
  • Price reported: $0.00 (typical for awards/grants).
  • Vesting: Options vest and become exercisable on the earlier of (a) June 18, 2026 or (b) the date of STAAR Surgical’s 2026 annual meeting, subject to LeBuhn’s continuous service (Footnote F1).
  • Plan: Granted under the Issuer’s Amended and Restated Omnibus Equity Incentive Plan (Footnote F2).
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Filing status: No late filing flag noted in the supplied data.

Context This transaction is a director compensation award (options) and is different from an open-market purchase or sale—options vest on a stated schedule and do not immediately change market holdings until exercised. Such grants are common for board compensation and do not, by themselves, indicate a personal buy or sell decision.